agilon health (NYSE:AGL) Stock Price Up 8.5% on Analyst Upgrade

agilon health, inc. (NYSE:AGL)’s stock price was up 8.5% during mid-day trading on Thursday after Sanford C. Bernstein raised their price target on the stock from $2.50 to $3.15. Sanford C. Bernstein currently has a market perform rating on the stock. agilon health traded as high as $3.07 and last traded at $3.06. Approximately 2,185,717 shares changed hands during mid-day trading, a decline of 49% from the average daily volume of 4,326,648 shares. The stock had previously closed at $2.82.

Several other equities analysts also recently issued reports on AGL. Evercore ISI reduced their price objective on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 8th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 target price on shares of agilon health in a research note on Tuesday, November 19th. TD Cowen decreased their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Needham & Company LLC began coverage on shares of agilon health in a research note on Friday, January 10th. They set a “hold” rating for the company. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $4.03.

Insiders Place Their Bets

In related news, Director Diana Mckenzie bought 12,500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The shares were acquired at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the acquisition, the director now owns 51,319 shares in the company, valued at $117,007.32. This represents a 32.20 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director John William Wulf purchased 45,000 shares of the firm’s stock in a transaction on Thursday, December 5th. The stock was bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 90,000 shares of company stock worth $198,100 over the last ninety days. 3.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. XTX Topco Ltd acquired a new position in agilon health in the 2nd quarter worth $211,000. Simplify Asset Management Inc. acquired a new position in shares of agilon health in the second quarter worth about $659,000. Ensign Peak Advisors Inc boosted its holdings in agilon health by 43.5% in the second quarter. Ensign Peak Advisors Inc now owns 140,937 shares of the company’s stock valued at $922,000 after purchasing an additional 42,750 shares during the last quarter. Bank of Montreal Can acquired a new stake in agilon health during the 2nd quarter valued at approximately $404,000. Finally, AQR Capital Management LLC increased its holdings in agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter.

agilon health Stock Performance

The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of -3.31 and a beta of 0.53. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a 50-day simple moving average of $2.07 and a 200-day simple moving average of $3.67.

agilon health (NYSE:AGL) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter last year, the company earned ($0.06) earnings per share. On average, analysts anticipate that agilon health, inc. will post -0.59 earnings per share for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.